Skip to main content
TipRanks
Go Ultimate75% OFF

Francesco Micheli Insider Profile

4 Followers

Francesco Micheli, former Ten Percent Owner at Intercept Pharma, holds 4.00M shares in Intercept Pharma (Ticker: ICPT). Most recently, Francesco Micheli Sold 1,500,000 shares of Intercept Pharma on Aug 17, 2020 for an estimated value of $71.25M.

Francesco Micheli's Trading History

ICPT
Intercept Pharma
Aug 17, 2020―Informative Sell71.25M$76.00M
ICPT
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 17, 2020Informative Sell$71.25M1,500,000$47.49+72.50%
May 15, 2020Informative Sell$50.39M595,578$84.60+78.50%
Dec 03, 2018Informative Sell$78.80M750,000$105.07-4.50%
Apr 09, 2018Informative Buy$25.00M390,625$64.00+57.30%
Apr 11, 2014Uninformative Sell$110.98M865,381$317.71―

You May Also Like

Francesco Micheli insider profile FAQ

What is the percentage of profitable transactions made by Francesco Micheli?
The percentage of profitable transactions made by Francesco Micheli is 75%.
What is the average return per transaction made by Francesco Micheli?
The average return per transaction made by Francesco Micheli is 50.90%.
What stocks does Francesco Micheli hold?
Francesco Micheli holds: ICPT stocks.
What was Francesco Micheli’s latest transaction?
Francesco Micheli’s latest transaction was an Informative Sell of $71.25M.
What was Francesco Micheli's most profitable transaction?
Francesco Micheli’s most profitable transaction was an Informative Sell of ICPT stock on May 15, 2020. The return on the trade was 78.50%.
What is Francesco Micheli's role in Intercept Pharma?
Francesco Micheli's role in Intercept Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.